
Gene Report
| Approved Symbol | GAS6 |
|---|---|
| Approved Name | growth arrest-specific 6 |
| Previous Symbol | AXLLG |
| Symbol Alias | AXSF, FLJ34709, DKFZp666G247 |
| Name Alias | AXL stimulatory factor |
| Location | 13q34 |
| Position | chr13:114523522-114567046 (-) |
| External Links |
Entrez Gene: 2621 Ensembl: ENSG00000183087 UCSC: uc001vud.3 HGNC ID: 4168 |
| No. of Studies (Positive/Negative) | 1(1/0)
|
| Type | Literature-origin |
| Name in Literature | Reference | Research Type | Statistical Result | Relation Description | |
|---|---|---|---|---|---|
| Growth arrest-specific 6 | Tochigi, 2008 | patients and normal controls | Genes differentially expressed in major depression Genes differentially expressed in major depression |
Network loading ...
Note:
1. The different color of the nodes denotes the level of the nodes.
| Genetic/Epigenetic Locus | Protein and Other Molecule | Cell and Molecular Pathway | Neural System | Cognition and Behavior | Symptoms and Signs | Environment | MDD |
2. User can drag the nodes to rearrange the layout of the network. Click the node will enter the report page of the node. Right-click will show also the menus to link to the report page of the node and remove the node and related edges. Hover the node will show the level of the node and hover the edge will show the evidence/description of the edge.
3. The network is generated using Cytoscape Web
| Approved Name | UniportKB | No. of Studies (Positive/Negative) | Source | |
|---|---|---|---|---|
| Growth arrest-specific protein 6 | Q14393 | 0(0/0) | Gene mapped |
Literature-origin GO terms | ||||
| ID | Name | Type | Evidence | |
|---|---|---|---|---|
| GO:0043491 | protein kinase B signaling cascade | biological process | IDA[16723520] | |
Gene mapped GO terms | ||||
| ID | Name | Type | Evidence | |
|---|---|---|---|---|
| GO:0002576 | platelet degranulation | biological process | TAS | |
| GO:0050766 | positive regulation of phagocytosis | biological process | IDA[18395422] | |
| GO:0035457 | cellular response to interferon-alpha | biological process | IDA[19657094] | |
| GO:0048146 | positive regulation of fibroblast proliferation | biological process | IDA[15184064] | |
| GO:0032720 | negative regulation of tumor necrosis factor production | biological process | IDA | |
| GO:0007155 | cell adhesion | biological process | TAS[16564713] | |
| GO:0050900 | leukocyte migration | biological process | TAS | |
| GO:0032148 | activation of protein kinase B activity | biological process | ISS | |
| GO:0070168 | negative regulation of biomineral tissue development | biological process | IDA | |
| GO:0070527 | platelet aggregation | biological process | TAS[16564713] | |
| GO:0006468 | protein phosphorylation | biological process | IDA[16359517] | |
| GO:0043066 | negative regulation of apoptotic process | biological process | IDA[19922767] | |
| GO:0072661 | protein targeting to plasma membrane | biological process | IDA[16359517] | |
| GO:0005615 | extracellular space | cellular component | IDA[8336730] | |
| GO:0007167 | enzyme linked receptor protein signaling pathway | biological process | IEA | |
| GO:0032689 | negative regulation of interferon-gamma production | biological process | IDA[18840707] | |
| GO:0045892 | negative regulation of transcription, DNA-dependent | biological process | IDA[18680538] | |
| GO:0007596 | blood coagulation | biological process | TAS | |
| GO:0097028 | dendritic cell differentiation | biological process | IEP[19657094] | |
| GO:0051897 | positive regulation of protein kinase B signaling cascade | biological process | IDA[16723520] | |
| GO:2000510 | positive regulation of dendritic cell chemotaxis | biological process | IDA[19657094] | |
| GO:0044267 | cellular protein metabolic process | biological process | TAS | |
| GO:0005576 | extracellular region | cellular component | TAS | |
| GO:0050711 | negative regulation of interleukin-1 secretion | biological process | IDA | |
| GO:0061098 | positive regulation of protein tyrosine kinase activity | biological process | IDA | |
| GO:0005515 | protein binding | molecular function | IPI[18760998] | |
| GO:0046718 | viral entry into host cell | biological process | IDA | |
| GO:0030296 | protein tyrosine kinase activator activity | molecular function | IDA | |
| GO:0010934 | macrophage cytokine production | biological process | IEA | |
| GO:0003104 | positive regulation of glomerular filtration | biological process | ISS | |
| GO:0009267 | cellular response to starvation | biological process | IEA | |
| GO:0040008 | regulation of growth | biological process | IEA | |
| GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | IDA[16723520] | |
| GO:0045860 | positive regulation of protein kinase activity | biological process | IDA[7854420] | |
| GO:0035690 | cellular response to drug | biological process | IDA[16359517] | |
| GO:0035754 | B cell chemotaxis | biological process | IDA[19922767] | |
| GO:0017187 | peptidyl-glutamic acid carboxylation | biological process | TAS | |
| GO:0097241 | hematopoietic stem cell migration to bone marrow | biological process | IDA[19922767] | |
| GO:0060090 | binding, bridging | molecular function | IDA | |
| GO:0006508 | proteolysis | biological process | TAS | |
| GO:0006909 | phagocytosis | biological process | IDA | |
| GO:0070588 | calcium ion transmembrane transport | biological process | IDA[18395422] | |
| GO:0071363 | cellular response to growth factor stimulus | biological process | IEA | |
| GO:0008283 | cell proliferation | biological process | TAS[16564713] | |
| GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | biological process | IDA[19657094] | |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | biological process | IDA[15184064] | |
| GO:0043687 | post-translational protein modification | biological process | TAS | |
| GO:0001961 | positive regulation of cytokine-mediated signaling pathway | biological process | IMP[18840707] | |
| GO:0007050 | cell cycle arrest | biological process | TAS[16564713] | |
| GO:0043277 | apoptotic cell clearance | biological process | IDA | |
| GO:0046813 | virion attachment, binding of host cell surface receptor | biological process | IDA | |
| GO:0005102 | receptor binding | molecular function | IDA[16359517]; IPI[7854420] | |
| GO:0005245 | voltage-gated calcium channel activity | molecular function | IDA[18395422] | |
| GO:0005788 | endoplasmic reticulum lumen | cellular component | TAS | |
| GO:0019079 | viral genome replication | biological process | IDA | |
| GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | molecular function | IDA[16723520] | |
| GO:0030971 | receptor tyrosine kinase binding | molecular function | IPI[7634325] | |
| GO:0085029 | extracellular matrix assembly | biological process | ISS | |
| GO:1900142 | negative regulation of oligodendrocyte apoptotic process | biological process | IDA[16723520] | |
| GO:0019064 | viral entry into host cell via membrane fusion with the plasma membrane | biological process | IDA | |
| GO:0001764 | neuron migration | biological process | IEA | |
| GO:2000669 | negative regulation of dendritic cell apoptotic process | biological process | IDA[19657094] | |
| GO:0005796 | Golgi lumen | cellular component | TAS | |
| GO:0032825 | positive regulation of natural killer cell differentiation | biological process | IDA[18840707] | |
| GO:0046827 | positive regulation of protein export from nucleus | biological process | IDA[18680538] | |
| GO:0005737 | cytoplasm | cellular component | IDA[18395422] | |
| GO:0071307 | cellular response to vitamin K | biological process | IDA[16359517] | |
| GO:0031100 | organ regeneration | biological process | IEA | |
| GO:0032008 | positive regulation of TOR signaling cascade | biological process | ISS | |
| GO:1900165 | negative regulation of interleukin-6 secretion | biological process | IDA | |
| GO:0031093 | platelet alpha granule lumen | cellular component | TAS | |
| GO:0010628 | positive regulation of gene expression | biological process | IDA[19657094] | |
| GO:0007165 | signal transduction | biological process | IDA[7854420]; TAS[16564713] | |
| GO:0005509 | calcium ion binding | molecular function | IEA | |
| GO:0048018 | receptor agonist activity | molecular function | IDA[15184064] | |
| GO:0001934 | positive regulation of protein phosphorylation | biological process | IDA[16723520]; ISS | |
| GO:0071333 | cellular response to glucose stimulus | biological process | ISS | |
| GO:0032715 | negative regulation of interleukin-6 production | biological process | IDA[19657094] | |
| GO:0016477 | cell migration | biological process | TAS[16564713] | |
| GO:0031589 | cell-substrate adhesion | biological process | IEA | |
| GO:0018105 | peptidyl-serine phosphorylation | biological process | IDA | |
| GO:2000533 | negative regulation of renal albumin absorption | biological process | ISS | |
| GO:0033159 | negative regulation of protein import into nucleus, translocation | biological process | IDA | |
| GO:2000352 | negative regulation of endothelial cell apoptotic process | biological process | IDA[18760998] | |
| GO:0033138 | positive regulation of peptidyl-serine phosphorylation | biological process | IDA[16723520] | |
| GO:0001786 | phosphatidylserine binding | molecular function | IDA | |
| GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | biological process | IDA[18680538] | |
| GO:0030168 | platelet activation | biological process | TAS | |
| GO:2000270 | negative regulation of fibroblast apoptotic process | biological process | IDA[16359517] | |
Gene mapped Reactome pathways | |||
| ID | Name | Description | |
|---|---|---|---|
| REACT_6900 | signaling in_immune_system | Humans are exposed to millions of potential pathogens daily,...... Humans are exposed to millions of potential pathogens daily, through contact, ingestion, and inhalation. Our ability to avoid infection depends on the adaptive immune system and during the first critical hours and days of exposure to a new pathogen, our innate immune system. More... | |
| REACT_798 | platelet activation | Platelet activation begins with the initial binding of adhes...... Platelet activation begins with the initial binding of adhesive ligands and of the excitatory platelet agonists. Intracellular signaling reactions will then enhance the adhesive and procoagulant properties of tethered platelets or of platelets circulating in the proximity. From the subendothelial adhesive substrates, collagen and possibly vWF are the main inducers of platelet activation. GP VI is the most potent collagen receptor initiating signal generation, an ability derived from its interaction with the FcRI gamma chain. This results in the phosphorylation of the gamma-chain by the non-receptor tyrosine kinases of the Src family. The phosphotyrosine motif is recognized by the SH2 domains of Syk, a tyrosine kinase. This association activates the Syk enzyme, leading to activation. Four PARs are identified, of which PARs 1 ,3 and 4 are substrates for thrombin. PAR 1 is the predominant thrombin receptor, PAR 3 is minimally expressed and PAR 4 is less responsive to thrombin. Platelets do not store PAR1, due to limited protein synthesis, they are capable of responding to thrombin only once. Platelet activation further results in the scramblase-mediated transport of negatively-charged phospholipids to the platelet surface. These phospholipids provide a catalytic surface (with the charge provided by phosphatidylserine and phosphatidylethanolamine) for the tenase complex (formed by the activated forms of the blood coagulation factors factor VIII and factor I). More... | |
| REACT_318 | platelet degranulation | Platelets function as exocytotic cells, secreting a plethora...... Platelets function as exocytotic cells, secreting a plethora of effector molecules at sites of vascular injury. Platelets contain a number of distinguishable storage granules including alpha granules, dense granules and lysosomes. On activation platelets release a variety of proteins, largely from storage granules but also as the result of apparent cell lysis. These act in an autocrine or paracrine fashion to modulate cell signaling. Alpha granules contain mainly polypeptides such as fibrinogen, von Willebrand factor, growth factors and protease inhibitors that that supplement thrombin generation at the site of injury. Dense granules contain small molecules, particularly adenosine diphosphate (ADP), adenosine triphosphate (ATP), serotonin and calcium, all recruit platelets to the site of injury. More... | |
| REACT_17015 | metabolism of_proteins | Protein metabolism comprises the pathways of translation, po...... Protein metabolism comprises the pathways of translation, post-translational modification and protein folding. More... | |
| REACT_1132 | gamma carboxylation_transport_and_amino_terminal_cleavage_of_proteins | A number of proteins, including eight required for normal bl...... A number of proteins, including eight required for normal blood clot formation and its regulation (Prothrombin (factor II), factor VII, factor IX, factor X, protein C, protein S, protein Z, and Gas6) share a sequence motif rich in glutamate residues near their amino termini. Carboxylation of the glutamate residues within this motif followed by removal of an aminoterminal propeptide is required for each of these proteins to function. These modifications occur as the proteins move through the endoplasmic reticulum and Golgi apparatus. More... | |
| REACT_12051 | cell surface_interactions_at_the_vascular_wall | Leukocyte extravasation is a rigorously controlled process t...... Leukocyte extravasation is a rigorously controlled process that guides white cell movement from the vascular lumen to sites of tissue inflammation. The powerful adhesive interactions that are required for leukocytes to withstand local flow at the vessel wall is a multistep process mediated by different adhesion molecules. Platelets adhered to injured vessel walls form strong adhesive substrates for leukocytes. For instance, the initial tethering and rolling of leukocytes over the site of injury are mediated by reversible binding of selectins to their cognate cell-surface glycoconjugates. Endothelial cells are tightly connected through various proteins, which regulate the organization of the junctional complex and bind to cytoskeletal proteins or cytoplasmic interaction partners that allow the transfer of intracellular signals. An important role for these junctional proteins in governing the transendothelial migration of leukocytes under normal or inflammatory conditions has been established. This pathway describes some of the key interactions that assist in the process of platelet and leukocyte interaction with the endothelium, in response to injury. More... | |
| REACT_604 | hemostasis | Two principal mechanisms limit blood loss after vascular inj...... Two principal mechanisms limit blood loss after vascular injury. Initially, platelets are activated, adhere to the site of the injury, and aggregate into a plug that limits blood loss. Proteins and small molecules released from activated platelets stimulate the plug formation process, and fibrinogen from the plasma forms bridges between activated platelets. These events allow the initiation of the clotting cascade, the second mechanism to limit blood loss. Negatively charged phospholipids exposed on cell surfaces at the site of injury and on activated platelets interact with tissue factor, setting off a cascade of reactions leading to generation of fibrin and the formation of an insoluble fibrin clot that strengthens the platelet plug. More... | |
| REACT_20 | formation of_platelet_plug | Hemostasis is a physiological response that culminates in th...... Hemostasis is a physiological response that culminates in the arrest of bleeding from an injured vessel. Acute vessel injury results in its constriction to reduce the loss of blood. Under normal conditions vascular endothelium supports vasodilation, inhibits platelet adhesion and activation, suppresses coagulation, enhances fibrin cleavage and is anti-inflammatory in character. Under acute vascular trauma vasoconstrictor mechanisms predominate and the endothelium becomes prothrombotic, procoagulatory and proinflammatory in nature. This is achieved by a reduction of endothelial dilating agents: adenosine, NO and prostacyclin; and the direct action of ADP, serotonin and thromboxane on vascular smooth muscle cells to elicit their contraction. The chief trigger for the change in endothelial function that leads to the formation of haemostatic thrombus is the loss of the endothelial cell barrier between blood and ECM components. Circulating platelets identify and discriminate areas of endothelial lesions; here, they adhere to the exposed sub endothelium. Their interaction with the various thrombogenic substrates and locally generated or released agonists results in platelet activation. This process is described as possessing two stages, firstly, adhesion - the initial tethering to a surface, and secondly aggregation - the platelet-platelet cohesion. More... | |
| REACT_1069 | post translational_protein_modification | After translation, many newly formed proteins undergo furthe...... After translation, many newly formed proteins undergo further covalent modifications that alter their functional properties and that are essentially irreversible under physiological conditions in the body. These modifications include the internal peptide bond cleavages that activate proenzymes, the attachment of oligosaccharide moieties to membrane-bound and secreted proteins, the attachment of lipid or glycolipid moieties that serve to anchor proteins to cellular membranes, and the vitamin K-dependent attachment of carboxyl groups to glutamate residues. More... | |
GAS6 related interactors from protein-protein interaction data in HPRD (count: 3)
